NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 203 filers reported holding NATERA INC in Q4 2019. The put-call ratio across all filers is 0.16 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,889,011 | +18.4% | 17,444 | 0.0% | 2.00% | +26.9% |
| Q1 2024 | $1,595,428 | +46.0% | 17,444 | 0.0% | 1.58% | +31.7% |
| Q4 2023 | $1,092,692 | +33.2% | 17,444 | -5.9% | 1.20% | -13.6% |
| Q3 2023 | $820,130 | -21.7% | 18,534 | -13.9% | 1.38% | +100.0% |
| Q2 2023 | $1,047,844 | -12.4% | 21,534 | 0.0% | 0.69% | -18.6% |
| Q1 2023 | $1,195,568 | +38.2% | 21,534 | 0.0% | 0.85% | -71.9% |
| Q4 2022 | $865,021 | -8.4% | 21,534 | 0.0% | 3.02% | -2.6% |
| Q3 2022 | $944,000 | +23.7% | 21,534 | 0.0% | 3.10% | +66.0% |
| Q2 2022 | $763,000 | -12.9% | 21,534 | 0.0% | 1.87% | +23.8% |
| Q1 2022 | $876,000 | -48.2% | 21,534 | +18.8% | 1.51% | -21.2% |
| Q4 2021 | $1,692,000 | -16.2% | 18,121 | 0.0% | 1.92% | -9.1% |
| Q3 2021 | $2,019,000 | -1.8% | 18,121 | 0.0% | 2.11% | -10.1% |
| Q2 2021 | $2,057,000 | +11.8% | 18,121 | 0.0% | 2.35% | -4.0% |
| Q1 2021 | $1,840,000 | -28.1% | 18,121 | -29.5% | 2.44% | -30.5% |
| Q4 2020 | $2,558,000 | +37.7% | 25,700 | 0.0% | 3.52% | -0.1% |
| Q3 2020 | $1,857,000 | +45.0% | 25,700 | 0.0% | 3.52% | -33.0% |
| Q2 2020 | $1,281,000 | +67.0% | 25,700 | 0.0% | 5.26% | +1848.1% |
| Q1 2020 | $767,000 | -11.4% | 25,700 | 0.0% | 0.27% | +3.8% |
| Q4 2019 | $866,000 | +2.7% | 25,700 | 0.0% | 0.26% | -7.8% |
| Q3 2019 | $843,000 | +18.9% | 25,700 | 0.0% | 0.28% | +6.0% |
| Q2 2019 | $709,000 | +33.8% | 25,700 | 0.0% | 0.27% | +25.5% |
| Q1 2019 | $530,000 | +44.8% | 25,700 | -1.9% | 0.21% | +22.5% |
| Q4 2018 | $366,000 | -34.1% | 26,200 | +12.9% | 0.17% | -27.0% |
| Q3 2018 | $555,000 | +27.6% | 23,200 | +0.4% | 0.24% | +37.0% |
| Q2 2018 | $435,000 | +81.2% | 23,100 | -10.8% | 0.17% | +31.1% |
| Q1 2018 | $240,000 | +5.7% | 25,900 | +2.4% | 0.13% | +106.2% |
| Q4 2017 | $227,000 | +26.1% | 25,300 | +80.7% | 0.06% | +23.1% |
| Q3 2017 | $180,000 | – | 14,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 503,094 | $54,480,049 | 52.98% |
| Kynam Capital Management, LP | 2,014,408 | $218,140,242 | 16.83% |
| Eagle Health Investments LP | 474,114 | $51,341,805 | 9.00% |
| Sofinnova Investments, Inc. | 1,550,280 | $167,879,821 | 8.72% |
| Eversept Partners, LP | 1,173,494 | $127,077,665 | 8.70% |
| Lagoda Investment Management, L.P. | 130,195 | $14,098,817 | 8.11% |
| Duquesne Family Office | 1,974,880 | $213,860 | 7.33% |
| Tri Locum Partners LP | 230,585 | $24,970,050 | 6.31% |
| PERKINS CAPITAL MANAGEMENT INC | 57,550 | $6,232 | 5.87% |
| PURA VIDA INVESTMENTS, LLC | 67,500 | $7,309,575 | 4.63% |